Danish biotech firm Symphogen enters multi-million dollar American partnership deal

The Danes will receive upfront payment and potential royalties for R&D efforts

Jan 4, 2016

The Danish biotech company Symphogen has entered into a strategic collaboration agreement with the US firm Baxalta that will see the Danes receive 175 million dollars (1.2 billion kroner) upfront, with the potential for future payments and royalties.

Symphogen specialises in antibody therapeutics for the treatment of cancer while Baxalta works with therapies for orphan diseases and underserved conditions in hematology, oncology and immunology.

Different strengths
According to the terms of the partnership, Symphogen will work on the development of six so-called novel immune checkpoint therapies in the treatment of rare diseases, whereafter Baxalta will have the exclusive option rights to commercialise the products worldwide.

Kirsten Drejer, the CEO of Symphogen, said the two parties brought different strengths to the table.

“Baxalta’s dedication to delivering transformative therapies and its global commercial presence make it an ideal strategic partner for Symphogen, as we complement Baxalta with R&D competencies within the immuno-oncology area,” she said.

“We look forward to providing Baxalta with innovative immuno-oncology product candidates under this broad collaboration.”

TOP STORIES

“Talents, start using AI tools now,” says Siri and Change.org founder

In an exclusive interview with The Copenhagen Post, the founder of Siri and Change.org, and currently VP of AI Experience at Airbnb, gives young talents advice on how to deal with the job market changed by artificial intelligence.
Testing free school meals for 20,000 kids and tax deduction for homeowners in 2025 Finance Act

The government has reached an agreement on next year’s Finance Act with SF and Radikale Venstre. A test on free school meals for a limited number of children will be introduced. Homeowners will get more options for deductions for home improvements
Make your voice heard as an expat

In my last op-ed, I made the case that we, expats living in Denmark, need to step up if we want to tackle the headaches that seem baked into expat life—e.g., counterintuitive laws and endless paperwork. With almost 16% of Denmark’s population made up of internationals, we actually have the numbers to influence real change. But after publishing the last op-ed, several readers contacted me and asked: Okay, but what can we actually do?
Danish politicians will double life science exports in a few years

“Strategy for life science” is a policy agreement to support the pharmaceutical industry’s opportunities to double exports to DKK 350 billion towards 2030
Royal House unveils new portraits of King Frederik and Queen Mary

Ten months after Frederik went from crown prince to king, new civil portraits of the new royal couple have been taken.
“Without internationals, we wouldn’t have the people we need,” says Fujifilm

Fujifilm’s Hillerød facility thrives with a diverse workforce, employing over 1,800 people from more than 65 nationalities. Morten Munk, Director of Global Alliance Management, highlights how the company’s rapid growth relies on attracting international talent due to Denmark’s limited pool of scientific professionals.

Connect club

Connect Club is your gateway to a vibrant programme of events and an international community in Denmark.

5 Dec: A guided tour of Christiansborg

Career

“Talents, start using AI tools now,” says Siri and Change.org founder

In an exclusive interview with The Copenhagen Post, the founder of Siri and Change.org, and currently VP of AI Experience at Airbnb, gives young talents advice on how to deal with the job market changed by artificial intelligence.
“Without internationals, we wouldn’t have the people we need,” says Fujifilm

Fujifilm’s Hillerød facility thrives with a diverse workforce, employing over 1,800 people from more than 65 nationalities. Morten Munk, Director of Global Alliance Management, highlights how the company’s rapid growth relies on attracting international talent due to Denmark’s limited pool of scientific professionals.
“Now the biggest challenge is to retain internationals”, says Ferring

Mads Hougaard, senior HR director at the pharmaceutical company, explains that “it is also a challenge for society itself. I think collaboration between institutions, companies, and stakeholders could be beneficial.”

Want to advertise your job with CPH Post?

Jobs